A Waltham compounding pharmacy has reopened after recently suspending operations.
OncoMed ceased operations in November 2012 after state inspectors found “issues with chemotherapy” medications at the site.
As a result, the company has updated its operations to comply with recently imposed Massachusetts Board of Pharmacy regulations, according to an OncoMed press release. The changes related to how oral medications are stored. The Massachusetts Pharmacy Board has approved OncoMed reopening, according to the company.
“The changes in procedure that we have undertaken in Waltham will improve the management of our workplace and ensure that we can continue to provide patients across New England with our high quality service,” OncoMed CEO Burt Zweigenhaft said in a statement. “Cancer patients are fighting the battle of their life; they should not have to worry that they will have access to the very best medications when they need them.”
The suspension came after recent unannounced inspections of the site. The meningitis outbreak at the New England Compounding Center in Framingham prompted the inspections.
Another Waltham compounding center has faced recent scrutiny. Infusion Resource surrendered its license in October of 2012 after the DPH cited it for cleanliness issues.